{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:22:14Z","timestamp":1760980934850},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"23","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Apoptosis plays a critical role in cellular homeostasis during development, immune responses, and tumorigenesis. Recent studies have identified a number of genes that control this process. We report here our identification of a novel cell survival-related gene (SRG) from a human expression cDNA library by functional cloning. SRG shows no significant nucleotide sequence homology to any known genes in the Genbank. Our fluorescence in situ hybridization analysis has estimated that SRG is located at 1p36, agreeing with the location at 1p36.22 in the human genome sequence. SRG encodes a putative protein of 172 amino acids, which is mainly located in the perinuclear region. Northern blotting analysis indicates that SRG is highly expressed in many human cancer cell lines although it is low in most tissues except liver and placenta. To investigate the function of SRG in apoptosis, we transfected SRG cDNA into BAF\/BO3 and B16\/F0 cells and induced apoptosis by cytokine\/serum deprivation. We found that SRG-transfected cells are resistant to apoptosis induced by cytokine\/serum deprivation. In addition, mice bearing SRG-transfected melanoma had more tumor formation and larger tumor growth. Melanoma transfected with antisense SRG showed significantly less tumor formation and smaller tumor growth. Interestingly, mouse SRG gene was also identified on chromosome 4 and blocking SRG expression with small interfering RNA promoted serum deprivation\u2013induced apoptosis of NIH3T3 cells. Our results show that SRG is a novel cell survival gene that critically controls apoptosis and tumor formation.<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-2176","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T20:48:14Z","timestamp":1133470094000},"page":"10716-10724","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification and Characterization of<i>Survival-Related Gene<\/i>, a Novel Cell Survival Gene Controlling Apoptosis and Tumorigenesis"],"prefix":"10.1158","volume":"65","author":[{"given":"Zeng-Rong","family":"Yuan","sequence":"first","affiliation":[{"name":"1Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey and"},{"name":"2Department of Immunology, Holland Laboratory of Biomedical Research, American Red Cross, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Holland Laboratory of Biomedical Research, American Red Cross, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Solomon","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Holland Laboratory of Biomedical Research, American Red Cross, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunyi","family":"Luo","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Holland Laboratory of Biomedical Research, American Red Cross, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[{"name":"2Department of Immunology, Holland Laboratory of Biomedical Research, American Red Cross, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey and"},{"name":"2Department of Immunology, Holland Laboratory of Biomedical Research, American Red Cross, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufang","family":"Shi","sequence":"additional","affiliation":[{"name":"1Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey and"},{"name":"2Department of Immunology, Holland Laboratory of Biomedical Research, American Red Cross, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2005,12,1]]},"reference":[{"key":"2022061621173951400_B1","doi-asserted-by":"crossref","unstructured":"Scott DW, Grdina T, Shi Y. T cells commit suicide, but B cells are murdered! J Immunol\u20081996; 156: 2352\u20136.","DOI":"10.4049\/jimmunol.156.7.2352"},{"key":"2022061621173951400_B2","doi-asserted-by":"crossref","unstructured":"Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci U S A\u20081996; 93: 2239\u201344.","DOI":"10.1073\/pnas.93.6.2239"},{"key":"2022061621173951400_B3","doi-asserted-by":"crossref","unstructured":"Sharma K, Wang RX, Zhang LY, et al. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther\u20082000; 88: 333\u201347.","DOI":"10.1016\/S0163-7258(00)00096-6"},{"key":"2022061621173951400_B4","doi-asserted-by":"crossref","unstructured":"Nagata S, Golstein P. The Fas death factor. Science\u20081995; 267: 1449\u201356.","DOI":"10.1126\/science.7533326"},{"key":"2022061621173951400_B5","doi-asserted-by":"crossref","unstructured":"Salih HR, Kiener PA. Alterations in Fas (CD 95\/Apo-1) and Fas ligand (CD178) expression in acute promyelocytic leukemia during treatment with ATRA. Leuk Lymphoma\u20082004; 45: 55\u20139.","DOI":"10.1080\/1042819031000139684"},{"key":"2022061621173951400_B6","doi-asserted-by":"crossref","unstructured":"Nagata S. Apoptosis mediated by the Fas system. Prog Mol Subcell Biol\u20081996; 16: 87\u2013103.","DOI":"10.1007\/978-3-642-79850-4_6"},{"key":"2022061621173951400_B7","doi-asserted-by":"crossref","unstructured":"Hoffman B, Liebermann DA. The proto-oncogene c-myc and apoptosis. Oncogene\u20081998; 17: 3351\u20137.","DOI":"10.1038\/sj.onc.1202592"},{"key":"2022061621173951400_B8","doi-asserted-by":"crossref","unstructured":"Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a\/ARF. Genes Dev\u20081999; 13: 2678\u201390.","DOI":"10.1101\/gad.13.20.2678"},{"key":"2022061621173951400_B9","unstructured":"Yang W, Bancroft L, Nicholas C, Lozonschi I, Augenlicht LH. Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet. Cancer Res\u20082003; 63: 4990\u20136."},{"key":"2022061621173951400_B10","unstructured":"James RM, Arends MJ, Plowman SJ, et al. K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomas. Mol Cancer Res\u20082003; 1: 820\u20135."},{"key":"2022061621173951400_B11","doi-asserted-by":"crossref","unstructured":"Ding HF, Fisher DE. Induction of apoptosis in cancer: new therapeutic opportunities. Ann Med\u20082002; 34: 451\u201369.","DOI":"10.1080\/078538902321012405"},{"key":"2022061621173951400_B12","doi-asserted-by":"crossref","unstructured":"Shi Y, Wang R, Sharma A, et al. Dissociation of cytokine signals for proliferation and apoptosis. J Immunol\u20081997; 159: 5318\u201328.","DOI":"10.4049\/jimmunol.159.11.5318"},{"key":"2022061621173951400_B13","doi-asserted-by":"crossref","unstructured":"Zamorano J, Wang HY, Wang R, Shi Y, Longmore GD, Keegan AD. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J Immunol\u20081998; 160: 3502\u201312.","DOI":"10.4049\/jimmunol.160.7.3502"},{"key":"2022061621173951400_B14","doi-asserted-by":"crossref","unstructured":"Li L, Qi X, Williams M, Shi Y, Keegan AD. Overexpression of insulin receptor substrate-1, but not insulin receptor substrate-2, protects a T cell hybridoma from activation-induced cell death. J Immunol\u20082002; 168: 6215\u201323.","DOI":"10.4049\/jimmunol.168.12.6215"},{"key":"2022061621173951400_B15","doi-asserted-by":"crossref","unstructured":"Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science\u20081992; 257: 212\u20134.","DOI":"10.1126\/science.1378649"},{"key":"2022061621173951400_B16","doi-asserted-by":"crossref","unstructured":"Kaneko S, Suzuki N, Koizumi H, Yamamoto S, Sakane T. Rescue by cytokines of apoptotic cell death induced by IL-2 deprivation of human antigen-specific T cell clones. Clin Exp Immunol\u20081997; 109: 185\u201393.","DOI":"10.1046\/j.1365-2249.1997.4191324.x"},{"key":"2022061621173951400_B17","doi-asserted-by":"crossref","unstructured":"Wang Y, He H, Zigler JS, Jr., et al. bFGF suppresses serum-deprivation-induced apoptosis in a human lens epithelial cell line. Exp Cell Res\u20081999; 249: 123\u201330.","DOI":"10.1006\/excr.1999.4450"},{"key":"2022061621173951400_B18","doi-asserted-by":"crossref","unstructured":"Ito Y, Arakawa M, Ishige K, Fukuda H. Comparative study of survival signal withdrawal- and 4-hydroxynonenal-induced cell death in cerebellar granule cells. Neurosci Res\u20081999; 35: 321\u20137.","DOI":"10.1016\/S0168-0102(99)00097-8"},{"key":"2022061621173951400_B19","doi-asserted-by":"crossref","unstructured":"Ogawa Y, Kobayashi T, Nishioka A, et al. Sudden termination of G-CSF injection leads to apoptosis of a large proportion of increased granulocytes. Oncol Rep\u20082001; 8: 1027\u20139.","DOI":"10.3892\/or.8.5.1027"},{"key":"2022061621173951400_B20","doi-asserted-by":"crossref","unstructured":"Antoku K, Liu Z, Johnson DE. IL-3 withdrawal activates a CrmA-insensitive poly(ADP-ribose) polymerase cleavage enzyme in factor-dependent myeloid progenitor cells. Leukemia\u20081998; 12: 682\u20139.","DOI":"10.1038\/sj.leu.2400992"},{"key":"2022061621173951400_B21","unstructured":"Mavilio F, Kreider BL, Valtieri M, et al. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G). Oncogene\u20081989; 4: 301\u20138."},{"key":"2022061621173951400_B22","doi-asserted-by":"crossref","unstructured":"Hasthorpe S, Carver JA, Rees D, Campbell ID. Metabolic effects of interleukin 3 on 32D cl23 cells analyzed by NMR. J Cell Physiol\u20081987; 133: 351\u20137.","DOI":"10.1002\/jcp.1041330220"},{"key":"2022061621173951400_B23","doi-asserted-by":"crossref","unstructured":"Maniatis T, Ptashne M, Barrell BG, Donelson J. Sequence of a repressor-binding site in the DNA of bacteriophage lambda. Nature\u20081974; 250: 394\u20137.","DOI":"10.1038\/250394a0"},{"key":"2022061621173951400_B24","doi-asserted-by":"crossref","unstructured":"Ragnarsson G, Eiriksdottir G, Johannsdottir JT, Jonasson JG, Egilsson V, Ingvarsson S. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer\u20081999; 79: 1468\u201374.","DOI":"10.1038\/sj.bjc.6690234"},{"key":"2022061621173951400_B25","doi-asserted-by":"crossref","unstructured":"Gibbs M, Stanford JL, McIndoe RA, et al. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet\u20081999; 64: 776\u201387.","DOI":"10.1086\/302287"},{"key":"2022061621173951400_B26","doi-asserted-by":"crossref","unstructured":"Bowden ET, Stoica GE, Wellstein A. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. J Biol Chem\u20082002; 277: 35862\u20138.","DOI":"10.1074\/jbc.M203963200"},{"key":"2022061621173951400_B27","doi-asserted-by":"crossref","unstructured":"Lindemann MJ, Benczik M, Gaffen SL. Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common \u03b3 (\u03b3c) receptor subunit. J Biol Chem\u20082003; 278: 10239\u201349.","DOI":"10.1074\/jbc.M209471200"},{"key":"2022061621173951400_B28","doi-asserted-by":"crossref","unstructured":"Chaudhary LR, Hruska KA. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem\u20082001; 81: 304\u201311.","DOI":"10.1002\/1097-4644(20010501)81:2<304::AID-JCB1045>3.0.CO;2-U"},{"key":"2022061621173951400_B29","doi-asserted-by":"crossref","unstructured":"Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell\u20081992; 69: 119\u201328.","DOI":"10.1016\/0092-8674(92)90123-T"},{"key":"2022061621173951400_B30","doi-asserted-by":"crossref","unstructured":"Conzen SD, Gottlob K, Kandel ES, et al. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol Cell Biol\u20082000; 20: 6008\u201318.","DOI":"10.1128\/MCB.20.16.6008-6018.2000"},{"key":"2022061621173951400_B31","doi-asserted-by":"crossref","unstructured":"Shim H, Chun YS, Lewis BC, Dang CV. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci U S A\u20081998; 95: 1511\u20136.","DOI":"10.1073\/pnas.95.4.1511"},{"key":"2022061621173951400_B32","doi-asserted-by":"crossref","unstructured":"Yamada M, Ishii N, Asao H, et al. Signal-transducing adaptor molecules STAM1 and STAM2 are required for T-cell development and survival. Mol Cell Biol\u20082002; 22: 8648\u201358.","DOI":"10.1128\/MCB.22.24.8648-8658.2002"},{"key":"2022061621173951400_B33","doi-asserted-by":"crossref","unstructured":"Bissonnette RP, McGahon A, Mahboubi A, Green DR. Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas. J Exp Med\u20081994; 180: 2413\u20138.","DOI":"10.1084\/jem.180.6.2413"},{"key":"2022061621173951400_B34","doi-asserted-by":"crossref","unstructured":"Rose MG, Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist\u20082004; 9: 247\u201358.","DOI":"10.1634\/theoncologist.9-3-247"},{"key":"2022061621173951400_B35","doi-asserted-by":"crossref","unstructured":"Rudin CM, Thompson CB. Transcriptional activation of short interspersed elements by DNA-damaging agents. Genes Chromosomes Cancer\u20082001; 30: 64\u201371.","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1066>3.0.CO;2-F"},{"key":"2022061621173951400_B36","doi-asserted-by":"crossref","unstructured":"van Slooten HJ, Clahsen PC, van Dierendonck JH, et al. Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. Br J Cancer\u20081996; 74: 78\u201385.","DOI":"10.1038\/bjc.1996.319"},{"key":"2022061621173951400_B37","doi-asserted-by":"crossref","unstructured":"Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci\u20082001; 26: 61\u20136.","DOI":"10.1016\/S0968-0004(00)01740-0"},{"key":"2022061621173951400_B38","doi-asserted-by":"crossref","unstructured":"Xerri L, Hassoun J, Devilard E, Birnbaum D, Birg F. BCL-X and the apoptotic machinery of lymphoma cells. Leuk Lymphoma\u20081998; 28: 451\u20138.","DOI":"10.3109\/10428199809058352"},{"key":"2022061621173951400_B39","doi-asserted-by":"crossref","unstructured":"Manion MK, O'Neill JW, Giedt CD, Kim KM, Zhang KY, Hockenbery DM. Bcl-XL mutations suppress cellular sensitivity to antimycin A. J Biol Chem\u20082004; 279: 2159\u201365.","DOI":"10.1074\/jbc.M306021200"},{"key":"2022061621173951400_B40","doi-asserted-by":"crossref","unstructured":"Karnauskas R, Niu Q, Talapatra S, et al. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo. Oncogene\u20082003; 22: 688\u201398.","DOI":"10.1038\/sj.onc.1206159"},{"key":"2022061621173951400_B41","unstructured":"Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res\u20081995; 55: 4438\u201345."},{"key":"2022061621173951400_B42","doi-asserted-by":"crossref","unstructured":"Mackey TJ, Borkowski A, Amin P, Jacobs SC, Kyprianou N. bcl-2\/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology\u20081998; 52: 1085\u201390.","DOI":"10.1016\/S0090-4295(98)00360-4"},{"key":"2022061621173951400_B43","doi-asserted-by":"crossref","unstructured":"Carthy CM, Yanagawa B, Luo H, et al. Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection. Virology\u20082003; 313: 147\u201357.","DOI":"10.1016\/S0042-6822(03)00242-3"},{"key":"2022061621173951400_B44","doi-asserted-by":"crossref","unstructured":"Cosulich SC, Savory PJ, Clarke PR. Bcl-2 regulates amplification of caspase activation by cytochrome c. Curr Biol\u20081999; 9: 147\u201350.","DOI":"10.1016\/S0960-9822(99)80068-2"},{"key":"2022061621173951400_B45","doi-asserted-by":"crossref","unstructured":"Marsden VS, Ekert PG, Van Delft M, Vaux DL, Adams JM, Strasser A. Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol\u20082004; 165: 775\u201380.","DOI":"10.1083\/jcb.200312030"},{"key":"2022061621173951400_B46","doi-asserted-by":"crossref","unstructured":"Scott SL, Higdon R, Beckett L, et al. BCL2 antisense reduces prostate cancer cell survival following irradiation. Cancer Biother Radiopharm\u20082002; 17: 647\u201356.","DOI":"10.1089\/108497802320970253"},{"key":"2022061621173951400_B47","doi-asserted-by":"crossref","unstructured":"Andersen MH, Svane IM, Kvistborg P, et al. Immunogenicity of Bcl-2 in cancer patients. Blood\u20082005; 105: 728\u201334.","DOI":"10.1182\/blood-2004-07-2548"},{"key":"2022061621173951400_B48","doi-asserted-by":"crossref","unstructured":"Huang Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene\u20082000; 19: 6627\u201331.","DOI":"10.1038\/sj.onc.1204087"},{"key":"2022061621173951400_B49","doi-asserted-by":"crossref","unstructured":"Hockenbery DM, Giedt CD, O'Neill JW, Manion MK, Banker DE. Mitochondria and apoptosis: new therapeutic targets. Adv Cancer Res\u20082002; 85: 203\u201342.","DOI":"10.1016\/S0065-230X(02)85007-2"},{"key":"2022061621173951400_B50","doi-asserted-by":"crossref","unstructured":"Manion MK, Hockenbery DM. Targeting BCL-2-related proteins in cancer therapy. Cancer Biol Ther\u20082003; 2: S105\u201314.","DOI":"10.4161\/cbt.209"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/23\/10716\/2539343\/10716-10724.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/23\/10716\/2539343\/10716-10724.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T18:10:55Z","timestamp":1683310255000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/23\/10716\/518855\/Identification-and-Characterization-of-Survival"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":50,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2005,12,1]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-2176","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,1]]}}}